Chiusura precedente | 20,41 |
Aperto | 20,56 |
Denaro | 21,00 x 200 |
Lettera | 21,06 x 300 |
Min-Max giorno | 20,38 - 21,23 |
Intervallo di 52 settimane | 6,08 - 34,94 |
Volume | |
Media Volume | 722.183 |
Capitalizzazione | 829,505M |
Beta (5 anni mensile) | 1,44 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -1,37 |
Prossima data utili | 30 lug 2024 - 05 ago 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 20,67 |
SUNNYVALE, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced preliminary revenue for the quarter ended September 30, 2023, and provided an update to full year 2023 revenue guidance. Preliminary Third Quarter 2023 Revenue Preliminary, unaudited third quarter 2023 revenue is expected to be approximately $44.4 million, an increase of 19% as compared to the prior year period.
Working with Leading Executive Search Firm to Identify Successor SUNNYVALE, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that CEO Erica Rogers plans to retire from the Company following the completion of a succession process. The Company is working with Spencer Stuart, a leading executive search firm. To ensure a smooth transition, Ms. Rogers will remain as President
SUNNYVALE, Calif., Sept. 04, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the CL King 21st Annual Best Ideas Conference. Management is scheduled to present on Monday, September 18, 2023, at 8:45 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https:/